The potency of chemokine receptor targeting in induction of CD8+ T cell responses is supported by previous studies demonstrating that MIP-1α-idiotypic tumor antigen fusion proteins are highly efficient at preventing cancer in mice[17], [18], [21], [22]. The gene discussed is CD8A; the disease is neoplasm.